Insider trades

William K. Heiden, Director of Atara Biotherapeutics ATRA, has filed 3 purchases and 0 sales on the open market. The latest trade was on 06/09.

William K. Heiden

Director
First filing
23/06/02
Trades
22 trades
Buys / sales
3 / 0
12-month net buying
No record
Last trade
06/09

Trading activity

Transactions

Trade type
MGNX
Open-market buy25/08/19–25/08/2025/08/21100,000 sh2 trades$1.51avg.$150,515+909.1%
Open-market buy23/11/1023/11/14100,000 sh$0.25$25,000+91.7%